Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$209.01 - $232.56 $85,485 - $95,117
-409 Reduced 2.63%
15,162 $3.31 Million
Q4 2023

Jan 19, 2024

SELL
$197.69 - $227.29 $7,907 - $9,091
-40 Reduced 0.26%
15,571 $3.54 Million
Q3 2023

Oct 12, 2023

BUY
$201.05 - $221.7 $15,279 - $16,849
76 Added 0.49%
15,611 $3.14 Million
Q2 2023

Jul 27, 2023

SELL
$211.93 - $241.33 $10,172 - $11,583
-48 Reduced 0.31%
15,535 $3.75 Million
Q1 2023

Apr 19, 2023

SELL
$213.32 - $257.83 $6,612 - $7,992
-31 Reduced 0.2%
15,583 $3.58 Million
Q4 2022

Jan 27, 2023

SELL
$203.72 - $248.97 $58,875 - $71,952
-289 Reduced 1.82%
15,614 $0
Q3 2022

Oct 21, 2022

BUY
$204.81 - $262.19 $31,131 - $39,852
152 Added 0.97%
15,903 $3.26 Million
Q2 2022

Jul 15, 2022

SELL
$213.86 - $277.87 $22,883 - $29,732
-107 Reduced 0.67%
15,751 $3.69 Million
Q1 2022

Apr 20, 2022

BUY
$259.82 - $298.18 $43,130 - $49,497
166 Added 1.06%
15,858 $4.18 Million
Q4 2021

Jan 26, 2022

BUY
$271.6 - $314.21 $52,147 - $60,328
192 Added 1.24%
15,692 $4.93 Million
Q3 2021

Oct 19, 2021

SELL
$274.82 - $308.34 $20,611 - $23,125
-75 Reduced 0.48%
15,500 $4.36 Million
Q2 2021

Jul 23, 2021

BUY
$251.87 - $278.14 $77,575 - $85,667
308 Added 2.02%
15,575 $4.3 Million
Q1 2021

May 05, 2021

BUY
$204.88 - $255.03 $24,585 - $30,603
120 Added 0.79%
15,267 $3.89 Million
Q4 2020

Jan 14, 2021

SELL
$186.91 - $214.42 $8,784 - $10,077
-47 Reduced 0.31%
15,147 $3.08 Million
Q3 2020

Oct 21, 2020

BUY
$167.03 - $201.3 $27,225 - $32,811
163 Added 1.08%
15,194 $2.86 Million
Q2 2020

Jul 15, 2020

BUY
$113.31 - $182.44 $163,053 - $262,531
1,439 Added 10.59%
15,031 $2.5 Million
Q1 2020

Apr 23, 2020

BUY
$104.32 - $195.28 $8,762 - $16,403
84 Added 0.62%
13,592 $1.72 Million
Q4 2019

Jan 15, 2020

BUY
$163.48 - $173.61 $4,250 - $4,513
26 Added 0.19%
13,508 $2.29 Million
Q3 2019

Oct 22, 2019

SELL
$159.77 - $178.1 $77,488 - $86,378
-485 Reduced 3.47%
13,482 $2.27 Million
Q2 2019

Aug 02, 2019

BUY
$144.16 - $172.9 $864 - $1,037
6 Added 0.04%
13,967 $2.42 Million
Q1 2019

Apr 19, 2019

SELL
$123.7 - $156.3 $3,092 - $3,907
-25 Reduced 0.18%
13,961 $2.14 Million
Q4 2018

Jan 15, 2019

SELL
$120.82 - $174.09 $15,464 - $22,283
-128 Reduced 0.91%
13,986 $1.77 Million
Q3 2018

Oct 18, 2018

BUY
$167.67 - $188.27 $92,218 - $103,548
550 Added 4.05%
14,114 $2.45 Million
Q2 2018

Jul 20, 2018

SELL
$160.33 - $189.41 $58,520 - $69,134
-365 Reduced 2.62%
13,564 $2.44 Million
Q1 2018

Apr 13, 2018

SELL
$161.53 - $178.11 $21,483 - $23,688
-133 Reduced 0.95%
13,929 $2.25 Million
Q4 2017

Jan 12, 2018

SELL
$147.99 - $163.95 $57,716 - $63,940
-390 Reduced 2.7%
14,062 $2.24 Million
Q4 2017

Jan 10, 2018

SELL
$147.99 - $163.95 $79,174 - $87,713
-535 Reduced 3.57%
14,452 $2.18 Million
Q3 2017

Oct 11, 2017

BUY
$149.47 - $160.56 $2.24 Million - $2.41 Million
14,987
14,987 $2.31 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Capital City Trust CO Portfolio

Follow Capital City Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital City Trust CO with notifications on news.